BIOCRATES Life Sciences AG to Launch Thermo Edition of its State-of-the-art Metabolomics-based Research Kit, AbsoluteIDQ® p150

INNSBRUCK, Austria, February 27, 2013 /PRNewswire/ –

Austrian BIOCRATES Life Sciences AG, prime developer of cutting-edge metabolite
metabolomics products, is about to launch the next edition of its well-established
research kit, AbsoluteIDQ(R) p150, for use with Thermo Scientific’s TSQ Vantage Triple
Stage Quadrupole Mass Spectrometer.

BIOCRATES Life Sciences announces the launch of a new edition of its well-established
research kit, AbsoluteIDQ(R) p150. The kit, which has been available for use with AB Sciex
and Waters mass spectrometry systems, has now been designed to also run on Thermo
Scientific’s TSQ Vantage Triple Stage Quadrupole Mass Spectrometer, enabling even more
research labs to harness the power of targeted metabolite quantification based on a
ready-to-use kit system. Combined with a robust new ion source, second-generation ion
optics and hyperbolic quadrupoles, the Thermo Scientific TSQ Vantage delivers the highest
sensitivity with the lowest chemical noise.

AbsoluteIDQ p150 provides extensive metabolic information from a single targeted
assay, quantifying 158 metabolites using a FIA-MS/MS method. It features the proprietary
MetIDQ(TM) software, requires minute sample volumes (10 microL), and is suitable for use
with a wide range of biological samples, making it an excellent choice for researchers
looking for a cost-effective solution to measure endogenous metabolites under
quality-controlled conditions in their own lab. The AbsoluteIDQ kits by BIOCRATES have
been successfully applied in many different areas, including diabetes, nephrology, sepsis,
and CNS disorders, in both clinical and pharmaceutical research.

About BIOCRATES

BIOCRATES Life Sciences AG is a leading biotechnology company focused on the
development of metabolomics products as well as in vitro diagnostics (IVDs) for early
disease and progression detection in areas such as nephrology, diabetes, oncology, and
endocrinology. Our mass spectrometry-based, standardized metabolomic kits and IVDs provide
unprecedented accuracy, precision, and multiplexing potential that will help revolutionize
the way personalized medicine is applied in R&D and diagnostics.

        Please also visit us at http://www.biocrates.com.
        BIOCRATES Life Sciences AG
        Martina Klocker
        Martina.Klocker@biocrates.com
        Tel. +43(0)512-579823

SOURCE BIOCRATES Life Sciences AG